BSYI (Biosyntech) Research & Development: $3.47 Mil (TTM As of Dec. 2009)


What is Biosyntech Research & Development?

Biosyntech BSYI Research & Development is $3.47 Mil as of Dec. 2009.

Research & Development is the aggregate amount of research and development expenses during the year. Biosyntech's Research & Development for the three months ended in Dec. 2009 was $0.89 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2009 was $3.47 Mil.

Biosyntech  (OTCPK:BSYI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Biosyntech Research & Development Related Terms

Biosyntech Research & Development Historical Data

* Premium members only.

The historical data trend for Biosyntech's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosyntech Research & Development Chart

Biosyntech Annual Data
Trend Mar00 Mar01 Mar02 Mar03 Mar04 Mar05 Mar06 Mar07 Mar08 Mar09
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.52 2.77 4.24 6.01 4.59

Biosyntech Quarterly Data
Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.27 1.02 0.68 0.89 0.89

Biosyntech Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2009 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.47 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $3.47 Mil mean?
Biosyntech (BSYI) has a Research & Development of $3.47 Mil as of Dec. 2009. Research and development expense is the total cost for research and development activities. View historical data on Biosyntech and its competitors.
Is Biosyntech's Research & Development too high?
Biosyntech's current Research & Development is $3.47 Mil.
How does Biosyntech's Research & Development compare to NSPX and HSTC?
Biosyntech's Research & Development of $3.47 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Biosyntech and its competitors. Biosyntech's current Research & Development is $3.47 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biosyntech stock overvalued right now?
Biosyntech (BSYI) has a current Research & Development of $3.47 Mil. The current Research & Development is $3.47 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Biosyntech (BSYI), the current Research & Development is $3.47 Mil as of Dec. 2009. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biosyntech Business Description

Address 475 Boulevard Armand-Frappier, Laval, QC, CAN, H7V 4B3
Biosyntech Inc is engaged in developing advanced biotherapeutics thermogels specifically designed for tissue repair and delivery of therapeutic agents. The company's products include BST-CarGel, BST-InPod, BST-DermOn, BST-Ossifil and BST-Ossifix and BST-Disc for intervertebral disc restoration.